ARCHIVES

In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR

This article is from The Cancer Letter archive.

Vol. 20 No. 15 | April 15, 1994

Download PDF Visit The Full Archive

Related Articles

Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers

April 25, 1980

Results of NSABP Studies Unchanged When Falsified Data is Excluded: Fisher

May 27, 1994

In Brief: Fischinger Hints of “New Player” At FCRF; Gigliotti Named Cancer Control Science Director

December 12, 1986

Cancer Letter Editor Finalist for Loeb Award

May 16, 2003

Onco TCS Induces Responses In Relapsed Aggressive NHL

February 28, 2003

CPRIT Executive Director Bill Gimson Is Out As Scandal Grows, Investigations Begin

December 14, 2012